Gastrin is a target of the β-catenin/TCF-4 growth-signaling pathway in a model of intestinal polyposis

Journal of Clinical Investigation

Volumn 106, Issue 4, 2000, Pages 533-539

  Koh, Theodore J ^a   Bulitta, Clemens J ^a   Fleming, John V ^a   Dockray, Graham J ^b   Varro, Andrea ^b   Wang, Timothy C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; GASTRIN;

ARTICLE; CELL GROWTH; COLORECTAL CANCER; CONTROLLED STUDY; GASTROINTESTINAL POLYPOSIS; GENE OVEREXPRESSION; HORMONE DEFICIENCY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; SURVIVAL;

EID: 0033856281     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI9476     Document Type: Article

References (45)

1. Smith, K.J., et al. 1993. The APC gene product in normal and tumor cells. Proc. Natl. Acad. Sci. USA. 90:2846-2850.
2. Kinzler, K.W., and Vogelstein, B. 1996. Lessons from hereditary colorectal cancer. Cell. 87:159-170.
3. Morin, P.J., et al. 1997. Activation of β-catenin-Tcf signaling in colon cancers by mutations in β-catenin or APC. Science. 275:1787-1790.
4. Korinek, V., et al. 1997. Constitutive transcriptional activation by a β-catenin-Tcf complex in APC-/-colon carcinoma. Science. 275:1784-1787.
5. Molenaar, M., et al. 1996. XTcf-3 transcription factor mediates β-catenin-induced axis formation in Xenopus embryos. Cell. 86:391-399.
6. Behrens, J., et al. 1996. Functional interaction of β-catenin with the transcription factor LEF-1. Nature. 382:638-642.
7. Korinek, V., et al. 1999. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat. Genet. 19:379-383.
8. He, T.C., et al. 1998. Identification of c-myc as a target of the APC pathway. Science. 281:1509-1512.
9. Tetsu, O., and McCormick, F. 1999. β-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 398:422-426.
10. He, T.C., Chan, T.A., Vogelstein, B., and Kinzler, K.W. 1999. PPARδ is an APC regulated target of nonsteroidal anti-inflammatory drugs. Cell. 99:335-345.
11. Watson, S.A., Michaeli, D., Morris, R.M., McWilliams, D., and Smith, A.M. 1999. The role of gastrin in the adenoma: carcinoma sequence in the colon. Digestion. 60:600. (Abstr.)
12. Nemeth, J., Taylor, B., Pauwels, S., Varro, A., and Dockray, G.J. 1993. Identification of progastrin derived peptides in colorectal carcinoma extracts. Gut. 34:90-95.
13. Van Solinge, W.W., Nielsen, F.C., Friis-Hansen, L., Falkmer, U.G., and Rehfeld, J.F. 1993. Expression but incomplete maturation of progastrin in colorectal carcinoma. Gastroenterology. 104:1099-1107.
14. Luttichau, H.R., van Solinge, W.W., Nielsen, F.C., and Rehfeld, J.F. 1993. Developmental expression of the gastrin and cholecystokinin genes in rat colon. Gastroenterology. 104:1092-1098.
15. Wang, T.C., et al. 1996. Processing and proliferative effects of human progastrin in transgenic mice. J. Clin. Invest. 98:1918-1929.
16. Koh, T.J., et al. 1999. Overexpression of glycine-extended gastrin in transgenic mice results in increased colonic proliferation. J. Clin. Invest. 103:1119-1126.
17. Koh, T.J., et al. 1997. Gastrin deficiency results in altered gastric differentiation and decreased colonie proliferation in mice. Gastroenterology. 113:1015-1025.
18. Morin, P.J., Vogelstein, B., and Kinzler, K.W. 1996. Apoptosis and APC in colorectal tumorigenesis. Proc. Natl. Acad. Sci. USA. 93:7950-7954.
19. Tillotson, L.G., Wang, T.C., and Brand, S.J. 1994. Activation of gastrin transcription in pancreatic insulinoma cells by a CACC promoter element and a 70-kDa sequence-specific DNA-binding protein. J. Biol. Chem. 269:2234-2240.
20. Kolligs, F.T., Hu, G., Dang, C.V., and Fearon, E.R. 1999. Neoplastic transformation of RK3E by mutant β-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression. Mol. Cell. Biol. 19:5696-5706.
21. Luongo, C., Moser, A.R., Gledhill, S., and Dove, W.F. 1994. Loss of APC in intestinal adenomas from Min mice. Cancer Res. 54:5947-5952.
22. Zaidi, N.H., et al. 1995. Transgenic expression of human MGMT protects against azoxymethane-induced aberrant crypt foci and G to A mutations in the K-ras oncogene of mouse colon. Carcinogenesis. 16:451-456.
23. Nakata, H., Wang, S.L., Chung, D.C., Westwick, J.K., and Tillotson, L.G. 1998. Oncogenic ras induces gastrin gene expression in colon cancer. Gastroenterology. 115:1144-1153.
24. Hollande, F., et al. 1997. Glycine-extended gastrin acts as an autocrine growth factor in a nontransformed colon cell line. Gastroenterology. 113:1576-1588.
25. Giese, K., Cox, J., and Grosschedl, R. 1992. The HMG domain of lymphoid enhancer factor1 bends DNA and facilitates assembly of functional nucleoprotein structures. Cell. 69:185-195.
26. Roose, J., and Clevers, H. 1999. TCF transcription factors: molecular switches in carcinogeneis. Biochim. Biophys. Acta. 1424:M23-M37.
27. van de Wetering, M., Oosterwegael, M., Dooijies, D., and Clevers, H. 1991. Identification and cloning of TCF-1, a T lymphocyte specific transcription factor containing a sequence-specific HMG box. EMBO J. 10:123-132.
28. Oshima, M., et al. 1996. Suppression of intestinal polyposis in APCΔ716 knockout mice by inhibition of cyclooxygenase 2. Cell. 87:803-809.
29. Todisco, A., Takeuchi, Y., Seva, C., Dickinson, C.J., and Yamda, T. 1995. Gastrin and glycine-extended progastrin processing intermediates induce different programs of early gene activation. J. Biol. Chem. 270:28337-28341.
30. Kowalski-Chauvel, A., Pradayrol, L., Vaysse, N., and Seva, C. 1997. Tyrosine phosphorylation of insulin receptor substrate-1 and activation of the PI-3-kinase pathway by glycine-extended gastrin precursors. Biochem. Biophys. Res. Commun. 236:687-692.
31. Seva, C., Dickinson, C.J., and Yamada, T. 1995. Growth promoting effects of glycine-extended progastrin. Science. 265:410-412.
32. Singh, P., Owlia, A., Espejo, R., and Dai, B. 1995. Novel gastrin receptor mediates mitogenic effects of gastrin and processing intermediates of gastrin in Swiss 3T3 fibroblasts. J. Biol. Chem. 270:28337-28341.
33. Baldwin, G.S. 1995. Binding of progastrin fragments to the 78-kDa binding protein. FEBS Lett. 359:97-100.
34. Biagini, P., et al. 1997. The human gastrin/cholecystokinin receptors: type B and type C expression in colonic tumors and cell lines. Life Sci. 61:1009-1018.
35. Monstein, H.J., et al. 1996. Cholecystokinin-A and cholecystokinin-B/gastrin receptor mRNA expression in the gastrointestinal tract and pancreas of the rat and man. Scand. J. Gastroenterol. 31:383-390.
36. Frucht, H., Gazdar, F., Park, J.A., Oie, H., and Jensen, R.T. 1992. Characterization of functional receptors for gastrointestinal hormones on human colon cancer cells. Cancer Res. 52:1114-1122.
37. Clerc, P., et al. 1997. Differential expression of the CCK-A and CCK-B/gastrin receptor genes in human cancers of the esophagus, stomach, and colon. Int. J. Cancer. 72:931-936.
38. Watson, S.A., et al. 1998. Expression of CCKB/gastrin receptor isoforms in gastro-intestinal tumour cells. Int. J. Cancer. 77:572-577.
39. Upp, J.R., Singh, P., Townsend, C.M., and Thompson, J.C. 1989. Clinical significance of gastrin receptors in human colon cancers. Cancer Res. 49:488-492.
40. Guan, R.J., Fu, Y., Holt, P.R., and Pardee, A.B. 1999. Association of k-ras mutations with p16 methylation in human colon cancer. Gastroenterology. 116:1063-1071.
41. Vogelstein, B., et al. 1988. Genetic alterations during colorectal-tumor development. N. Engl. J. Med. 319:525-532.
42. Fearon, E.R. 1995. Molecular genetics of colorectal cancer. Ann. NY Acad. Sci. 768:101-109.
43. Lityak, J.A., et al. 1999. JMV1 155: a novel inhibitor of glycine-extended progastrin-mediated growth of a human colon cancer in vivo. Anticancer Res. 19:45-49.
44. Singh, P., et al. 1996. Gastrin gene expression is required for the proliferation and tumorigenicity of human colon cancer cells. Cancer Res. 56:4111-4115.
45. Watson, S.A., et al. 1996. Gastrimmune raises antibodies that neutralize amidated and glycine-extended gastrin-17 and inhibit the growth of colon cancer. Cancer Res. 56:880-885.